About

Our Capital Creates Change

We collaborate with incubators, innovation hubs, academic institutions, and life sciences companies to identify the next promising ventures. Our pipeline of emerging companies is fuelled not only by our extensive sector network but also by decades of experience in private equity, asset management, and private wealth management.

Our AIFM registration signifies our commitment to a stringent regulatory framework that promotes transparency, stability, and confidence in the alternative investment fund sector.

Investment Strategy

Investment Strategy

CLARMA CAPITAL focuses on investing in European life sciences startups, particularly those at the forefront of medical device, medicinal product, and diagnostic innovation. Our team, located in London, Switzerland, Dublin, and Central Europe, is committed to nurturing breakthroughs in this dynamic sector.

We invest in:

  • Seed and early-stage European life sciences companies.
  • Regulated products (medicinal products, medical devices, diagnostics) grounded in solid scientific principles with the potential to change the standard of care.
  • Significant addressable markets with high- likelihood of market acceptance.
  • Capable, experienced, and commercially- minded management team.
  • Clearly defined exit plan, preferably by acquisitions or mergers.

Impact

Impact

Through early-stage investments, we aim to drive substantial growth and propel transformative change in healthcare. We create impact by leveraging our decades of experience in senior-level operational roles within the life sciences sector and we utilise our extensive network of specialists across diverse disciplines. For us, impact also encompasses a commitment to ESG, and therefore, we work diligently to ensure that all our portfolio companies implement and maintain systems and processes that are reflective of this commitment.

Access to Capital

Assisting portfolio companies in securing follow-on funding including intros to VCs and other investors

Strategic Partnerships

Facilitating strategic partnerships and collaborations with other life sciences companies, hospitals, research institutes & industry stakeholders

Operational Efficiency

Helping companies improve their operational processes, cost management and scalability

Business Development

Supporting business development activities including identifying potential customers, partners or acquisition opportunities

Regulatory Guidance

Assisting portfolio companies in navigating complex regulatory landscape incl. supporting FDA approvals and compliance